Apple's iPhone 14 has lots of new safety features, but it still needs some protection of its own. PCMag PCMag.com and PC Magazine are among the federally registered ...

Catalyst Pharmaceuticals settles patent litigation with Teva, delaying generic Firdapse launch until 2035. Legal actions against other defendants remain ongoing.

which is facing a case focused on Catalyst’s Firdapse patent that expires in 2037. In the Notice Letter in January 2023, Teva stated that it intended to market a generic version of Firdapse ...